Erasca (ERAS) News Today $1.44 -0.03 (-1.71%) As of 03:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Erasca (NASDAQ:ERAS) Reaches New 52-Week Low - Here's What HappenedErasca (NASDAQ:ERAS) Sets New 1-Year Low - Here's What HappenedFebruary 7, 2025 | marketbeat.comErasca (NASDAQ:ERAS) Stock Price Down 6.1% - Time to Sell?Erasca (NASDAQ:ERAS) Trading Down 6.1% - Time to Sell?February 3, 2025 | marketbeat.comErasca (NASDAQ:ERAS) Shares Up 6.6% - Here's What HappenedErasca (NASDAQ:ERAS) Trading Up 6.6% - Here's WhyJanuary 31, 2025 | marketbeat.comErasca to Present at the Guggenheim Securities SMID Cap Biotech ConferenceJanuary 31, 2025 | globenewswire.comErasca: Future 'Streamlined' But Still UncertainJanuary 28, 2025 | seekingalpha.comErasca's Naporafenib Is Shaping Up Nicely For NRASm MelanomaJanuary 27, 2025 | seekingalpha.comErasca (NASDAQ:ERAS) Is In A Good Position To Deliver On Growth PlansJanuary 21, 2025 | finance.yahoo.comErasca (NASDAQ:ERAS) Shares Down 6.2% - What's Next?Erasca (NASDAQ:ERAS) Shares Down 6.2% - Here's WhyJanuary 16, 2025 | marketbeat.comBank of America Securities Reaffirms Their Buy Rating on Erasca (ERAS)January 15, 2025 | markets.businessinsider.comErasca, Inc. (NASDAQ:ERAS) Shares Acquired by Barclays PLCBarclays PLC boosted its holdings in Erasca, Inc. (NASDAQ:ERAS - Free Report) by 627.5% in the third quarter, according to its most recent Form 13F filing with the SEC. The fund owned 343,930 shares of the company's stock after purchasing an additional 296,657 shares during the period. Barclays PLCJanuary 15, 2025 | marketbeat.comErasca Highlights Strategic Focus at Healthcare ConferenceJanuary 13, 2025 | tipranks.comErasca (NASDAQ:ERAS) Trading Down 8.7% - What's Next?Erasca (NASDAQ:ERAS) Shares Down 8.7% - Here's WhyJanuary 10, 2025 | marketbeat.comErasca (NASDAQ:ERAS) Trading Up 3% - What's Next?Erasca (NASDAQ:ERAS) Stock Price Up 3% - Time to Buy?January 8, 2025 | marketbeat.comB of A Securities Upgrades Erasca (ERAS)January 8, 2025 | msn.comErasca upgraded to Buy from Neutral at BofAJanuary 7, 2025 | markets.businessinsider.comErasca (NASDAQ:ERAS) Upgraded to Buy at Bank of AmericaBank of America raised shares of Erasca from a "neutral" rating to a "buy" rating and set a $5.00 target price on the stock in a research report on Tuesday.January 7, 2025 | marketbeat.comErasca to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceJanuary 7, 2025 | markets.businessinsider.comErasca (NASDAQ:ERAS) Shares Gap Up - What's Next?Erasca (NASDAQ:ERAS) Shares Gap Up - Here's What HappenedJanuary 7, 2025 | marketbeat.comErasca (NASDAQ:ERAS) Trading Up 7.6% - Should You Buy?Erasca (NASDAQ:ERAS) Shares Up 7.6% - Should You Buy?January 2, 2025 | marketbeat.comGeode Capital Management LLC Raises Stock Position in Erasca, Inc. (NASDAQ:ERAS)Geode Capital Management LLC grew its holdings in Erasca, Inc. (NASDAQ:ERAS - Free Report) by 36.0% in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 4,502,698 shares of the company's stock after purchasing an additional 1,190,807 shares duJanuary 1, 2025 | marketbeat.comBarclays PLC Increases Stock Holdings in Erasca, Inc. (NASDAQ:ERAS)Barclays PLC lifted its stake in shares of Erasca, Inc. (NASDAQ:ERAS - Free Report) by 627.5% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 343,930 shares of the company's stock after buying an additional 296,657 shares durinDecember 31, 2024 | marketbeat.comState Street Corp Acquires 3,569,440 Shares of Erasca, Inc. (NASDAQ:ERAS)State Street Corp lifted its holdings in shares of Erasca, Inc. (NASDAQ:ERAS - Free Report) by 145.2% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 6,027,620 shares of the company's stock after acquiring an additional 3,569,440 sDecember 25, 2024 | marketbeat.comUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Acquires New Stake in Erasca, Inc. (NASDAQ:ERAS)UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC bought a new position in Erasca, Inc. (NASDAQ:ERAS - Free Report) during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 364,085 shares of the company'sDecember 19, 2024 | marketbeat.comErasca (NASDAQ:ERAS) Shares Gap Up - Should You Buy?Erasca (NASDAQ:ERAS) Shares Gap Up - Here's What HappenedDecember 17, 2024 | marketbeat.comPoint72 Asset Management L.P. Reduces Holdings in Erasca, Inc. (NASDAQ:ERAS)Point72 Asset Management L.P. reduced its stake in Erasca, Inc. (NASDAQ:ERAS - Free Report) by 93.9% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 63,599 shares of the company's stock after selling 971,628 shares during the quaDecember 14, 2024 | marketbeat.comCharles Schwab Investment Management Inc. Purchases 390,209 Shares of Erasca, Inc. (NASDAQ:ERAS)Charles Schwab Investment Management Inc. increased its stake in Erasca, Inc. (NASDAQ:ERAS - Free Report) by 29.3% during the third quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 1,723,630 shares of the company's stock after purchasing an additional 390December 14, 2024 | marketbeat.comFrazier Life Sciences Management L.P. Increases Position in Erasca, Inc. (NASDAQ:ERAS)Frazier Life Sciences Management L.P. grew its holdings in shares of Erasca, Inc. (NASDAQ:ERAS - Free Report) by 19.6% in the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 19,391,687 shares of the company's stock after purchasing an additional 3,175,471 shares duDecember 10, 2024 | marketbeat.comErasca, Inc. (NASDAQ:ERAS) Stock Position Decreased by Janus Henderson Group PLCJanus Henderson Group PLC decreased its position in Erasca, Inc. (NASDAQ:ERAS - Free Report) by 49.7% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 4,109,548 shares of the company's stock after selling 4,068,544 shares durDecember 9, 2024 | marketbeat.comWalleye Capital LLC Boosts Holdings in Erasca, Inc. (NASDAQ:ERAS)Walleye Capital LLC raised its stake in Erasca, Inc. (NASDAQ:ERAS - Free Report) by 41.3% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 949,557 shares of the company's stock after acquiring an addiDecember 4, 2024 | marketbeat.comFred Alger Management LLC Takes Position in Erasca, Inc. (NASDAQ:ERAS)Fred Alger Management LLC bought a new stake in Erasca, Inc. (NASDAQ:ERAS - Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 230,854 shares of the company's stock, valued at approximately $630,000. FredDecember 2, 2024 | marketbeat.comErasca, Inc. (NASDAQ:ERAS) Shares Sold by Sio Capital Management LLCSio Capital Management LLC trimmed its holdings in shares of Erasca, Inc. (NASDAQ:ERAS - Free Report) by 22.8% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,219,186 shares of the company's stock aftNovember 29, 2024 | marketbeat.comErasca initiated with a Buy at JefferiesNovember 19, 2024 | markets.businessinsider.comJefferies Initiates Coverage of Erasca (ERAS) with Buy RecommendationNovember 19, 2024 | msn.comErasca (NASDAQ:ERAS) Shares Gap Up - Time to Buy?Erasca (NASDAQ:ERAS) Shares Gap Up - Still a Buy?November 18, 2024 | marketbeat.comErasca, Inc. (NASDAQ:ERAS) Receives Average Recommendation of "Moderate Buy" from BrokeragesErasca, Inc. (NASDAQ:ERAS - Get Free Report) has been assigned an average rating of "Moderate Buy" from the five research firms that are presently covering the firm, Marketbeat Ratings reports. One equities research analyst has rated the stock with a hold rating and four have assigned a buy ratinNovember 18, 2024 | marketbeat.comErasca (NASDAQ:ERAS) Now Covered by Jefferies Financial GroupJefferies Financial Group assumed coverage on shares of Erasca in a research report on Monday. They issued a "buy" rating and a $6.00 price objective for the company.November 18, 2024 | marketbeat.comWhat is HC Wainwright's Estimate for Erasca FY2024 Earnings?Erasca, Inc. (NASDAQ:ERAS - Free Report) - Research analysts at HC Wainwright increased their FY2024 earnings per share (EPS) estimates for shares of Erasca in a research report issued to clients and investors on Wednesday, November 13th. HC Wainwright analyst A. Maldonado now forecasts that theNovember 18, 2024 | marketbeat.comBank of America Securities Sticks to Its Hold Rating for Erasca (ERAS)November 15, 2024 | markets.businessinsider.comErasca, Inc. Reports Strong Progress in Oncology PipelineNovember 15, 2024 | markets.businessinsider.comErasca, Inc.: Erasca Reports Third Quarter 2024 Business Updates and Financial ResultsNovember 13, 2024 | finanznachrichten.deErasca (ERAS) Gets a Buy from Morgan StanleyNovember 13, 2024 | markets.businessinsider.comErasca’s Innovative Naporafenib Shows Promise in NRAS-mutant Melanoma, Garnering Buy Rating from AnalystNovember 13, 2024 | markets.businessinsider.comErasca's (ERAS) Buy Rating Reiterated at HC WainwrightHC Wainwright reissued a "buy" rating and issued a $6.00 target price on shares of Erasca in a research report on Wednesday.November 13, 2024 | marketbeat.comErasca Reports Third Quarter 2024 Business Updates and Financial ResultsNovember 12, 2024 | globenewswire.comErasca to Present at Upcoming Investor ConferencesNovember 5, 2024 | globenewswire.comErasca Insiders Added US$1.95m Of Stock To Their HoldingsOctober 31, 2024 | finance.yahoo.comErasca (NASDAQ:ERAS) Stock Price Up 3.8% - Here's WhyErasca (NASDAQ:ERAS) Trading 3.8% Higher - What's Next?October 29, 2024 | marketbeat.comErasca (NASDAQ:ERAS) Trading Down 3.4% - What's Next?Erasca (NASDAQ:ERAS) Stock Price Down 3.4% - Should You Sell?October 28, 2024 | marketbeat.comErasca (NASDAQ:ERAS) PT Raised to $3.50The Goldman Sachs Group increased their price target on Erasca from $3.00 to $3.50 and gave the stock a "buy" rating in a report on Friday.October 25, 2024 | marketbeat.comErasca announces clinical progress for naporafenibOctober 25, 2024 | markets.businessinsider.com Get Erasca News Delivered to You Automatically Sign up to receive the latest news and ratings for ERAS and its competitors with MarketBeat's FREE daily newsletter. Email Address ERAS Media Mentions By Week ERAS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ERAS News Sentiment▼0.000.60▲Average Medical News Sentiment ERAS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ERAS Articles This Week▼02▲ERAS Articles Average Week Get Erasca News Delivered to You Automatically Sign up to receive the latest news and ratings for ERAS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Vera Therapeutics News Iovance Biotherapeutics News Praxis Precision Medicines News Galapagos News Wave Life Sciences News Apogee Therapeutics News Evotec News Disc Medicine News Arcutis Biotherapeutics News Amphastar Pharmaceuticals News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ERAS) was last updated on 2/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon “obliterates” Bill Gates?All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...Altimetry | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored My 2025 AI BlueprintI first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...Weiss Ratings | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredBetter than Bitcoin – and potentially more profitableThe world is obsessed with Bitcoin again... And for a good reason: It just soared beyond $100,000. Bitcoin ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Erasca, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Erasca With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ERAS Stock Alerts